AstraZeneca Plc said its experimental hypertension pill reduced blood pressure by more than twice as much as standard treatment in a large late-stage study, bolstering its chances of competing in a crowded field.
www.bloomberg.com
#Astra #Pill #Cuts #HardtoTreat #Blood #Pressure #LateStage #Trial
Astra Pill Cuts Hard-to-Treat Blood Pressure in Late-Stage Trial
